The use of SSAs yielded a clinically significant median PFS of 7.9 months in our study that did not reach statistical significance.
← all excerpts
Well-Differentiated Grade 3 Neuroendocrine Tumors: Characteristics, Treatments, and Outcomes From a Population-Based Study.
1
—
—